Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 17, 2022
Multiple rechallenges with anti-PD-1 immunotherapy in patients with checkpoint inhibitor-related pneumonitis: A report of two casesZheng Yan, Shuna Yao, Junhui Yuan, et al.
Cancer Management and Research|January 10, 2022
Primary Testicular Lymphoma with Central Nervous System Relapse Was Successfully Treated by a Chemo-Free Regimen: A Case Report and Literature ReviewZheng Yan, Shuna Yao, Yuanyuan Wang, et al.
Annals of Clinical Epidemiology|December 15, 2025
Secondary Analysis of Randomized Controlled Trials: Methodological Considerations and Best PracticesQingyao Shang, Shuna Yao, Meishuo Ouyang, et al.
Frontiers in Immunology|February 24, 2023
Treatment of extranodal NK/T-cell lymphoma: From past to futureZheng Yan, Shuna Yao, Zhizhong Wang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 21, 2014
[Efficacy and safety of fixed dose rate gemcitabine infusion in combination with docetaxel in patients with relapsed/refractory soft tissue sarcoma]Zhihua Yao, Shujun Yang, Yan Zhao, et al.
Annals of Clinical Epidemiology|July 23, 2025
Designing Single-Arm Clinical Trials: Principles, Applications, and Methodological ConsiderationsShuna Yao, Qingyao Shang, Meishuo Ouyang, et al.
Frontiers in Immunology|December 13, 2021
Anti-Angiogenic Agent Combined with Anti-PD-1 Immunotherapy Showed Activity in Patients With Classical Hodgkin Lymphoma Who Have Failed Immunotherapy: A Retrospective Case Report StudyZheng Yan, Jialin Ma, Shuna Yao, et al.
Cancer Innovation|February 2, 2026
AI and Big Data in Oncology: A Physician-Centered Perspective on Emerging Clinical and Research ApplicationsBinliang Liu, Qingyao Shang, Jun Li, et al.
Oncology Letters|August 22, 2018
MicroRNA-376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphomaShuna Yao, Yanyan Liu, Zhihua Yao, et al.
Frontiers in Oncology|December 28, 2020
Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature ReviewZheng Yan, Shuna Yao, Yanyan Liu, et al.
Pageof 2